https://scholars.lib.ntu.edu.tw/handle/123456789/629790
標題: | Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study | 作者: | Huang, Huiqiang Zhu, Jun MING YAO Kim, Tae Min Yoon, Dok Hyun Cho, Seok-Goo Eom, Hyeon Seok Lim, Soon Thye Yeh, Su-Peng Song, Yuqin Kwong, Yok Lam Kim, Jin Seok Jin, Jie Shi, Yuankai Kim, HyeJin Qing, Min Zhou, Tianyuan Gao, Grace Dong, Zongqi Qi, Ming Kim, Won Seog |
關鍵字: | CD38; Daratumumab; NK/T-cell lymphoma | 公開日期: | 15-二月-2021 | 出版社: | BMC | 卷: | 14 | 期: | 1 | 起(迄)頁: | 25 | 來源出版物: | Journal of hematology & oncology | 摘要: | Natural killer/T-cell lymphoma (NKTCL) is a disease with limited treatment options and poor outcomes. Daratumumab monotherapy demonstrated clinical activity in a single-patient case report. We present data from the primary analysis of a phase 2 study of daratumumab monotherapy in relapsed or refractory (R/R) NKTCL. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/629790 | ISSN: | 1756-8722 | DOI: | 10.1186/s13045-020-01020-y |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。